Novel therapeutic targets for nonalcoholic fatty liver disease.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a serious public health problem. It is now estimated to affect 30% of adults and about 10% of children in the U.S. Hispanics are disproportionably affected with not only higher rates of NAFLD but also more severe disease. Treatment options are currently limited.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Expert Opin. Ther. Targets

Title: Expert opinion on therapeutic targets

ISSN (Electronic): 1744-7631

ISSN (Print): 1472-8222

Publication date (Electronic): Jul 2013

Volume: 17

Issue: 7

Affiliations

[1 ] Rady Children's Hospital, Department of Pediatric Gastroenterology, University of California-San Diego, CA 92123, USA. afeldstein@ucsd.edu

Article

DOI: 10.1517/14728222.2013.789502

PubMed ID: 23600493

SO-VID: 73a9dc2f-bdeb-4451-8ceb-9bcb2526103f

History

Data availability:

Comments

Comment on this article

scite_

Cited by 9

See all cited by